Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa

BACKGROUND: The development of a safe and effective vaccine against human immunodeficiency virus type 1 (HIV-1) for prevention mother-to-child transmission of HIV would significantly advance the goal of eliminating HIV infection in children. Safety and feasibility results from Phase I, randomized, d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kintu, Kenneth, Andrew, Philip, Musoke, Philippa, Richardson, Paul, Asiimwe-Kateera, Brenda, Nakyanzi, Teopista, Wang, Lei, Fowler, Mary Glenn, Emel, Lynda, Ou, San-San, Baglyos, Lynn, Gurunathan, Sanjay, Zwerski, Sheryl, Jackson, J Brooks, Guay, Laura
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3625520/
https://ncbi.nlm.nih.gov/pubmed/23221981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31827f1c2d
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller